Showing results (1-10 of 1,005) with videos related to
Sort By:
Pageof 101
Wiener Klinische Wochenschrift|January 23, 2002
Infliximab in severe steroid-refractory ulcerative colitis: a pilot studyA Kaser, T Mairinger, W Vogel, et al.Clinical and Experimental Immunology|October 30, 1999
Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathwayA Kaser, B Enrich, O Ludwiczek, et al.Current Pharmaceutical Design|October 20, 1999
Interferons and their role In inflammationH Tilg, A KaserCellular and Molecular Biology (Noisy-Le-Grand, France)|August 15, 2001
Interferon-alpha in inflammation and immunityA Kaser, H TilgGut|July 13, 2005
Predicting mortality by the Glasgow alcoholic hepatitis score: the long awaited progress?H Tilg, A KaserIdrugs : the Investigational Drugs Journal|October 4, 2005
IL-6 and arthritis: a detrimental or beneficial mediator?H Tilg, A KaserEuropean Cytokine Network|September 22, 2001
Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell deathO Ludwiczek, A Kaser, R O Koch, et al.International Journal of Colorectal Disease|January 28, 2003
Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseasesO Ludwiczek, A Kaser, H TilgCytokine|March 26, 1998
Differential regulation of interleukin 4 and interleukin 13 production by interferon alphaA Kaser, C Molnar, H TilgCytokine|October 20, 1999
Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expressionA Kaser, S Nagata, H TilgPageof 101